Speaker illustration

Assistant Professor Valery Ionin

Pavlov University, Saint-Petersburg (Russian Federation)

Cardiotrophin-1 and components of metabolic syndrome: what is the role in the development of atrial fibrillation?

Event: EHRA 2021

Topic: Pathophysiology and Mechanisms, Other

Session: Pathophysiology of atrial fibrillation and beyond II

Thumbnail

Profibrogenic biomarkers and severity of left atrial fibrosis in patients with atrial fibrillation and metabolic syndrome: is it possible to predict the effectiveness of therapy?

Event: ESC Congress 2019

Topic: Atrial Stressors

Session: Epidemiology of atrial fibrillation

Thumbnail

Galectin-3 as a risk factor recurrence of atrial fibrillation in patients with metabolic syndrome

Event: EHRA 2019

Topic: Rhythm Control, Antiarrhythmic Drugs

Session: Atrial Fibrillation - Treatment

Thumbnail

Epicardial adipose tissue and transforming growth factor-beta1 - risk factors of atrial fibrillation in patients with metabolic syndrome.

Event: EuroEcho-Imaging 2018

Topic: Technology

Session: Young Investigator Award session - Basic Science

Thumbnail

Left atrium fibrosis, epicardial fat and galectin-3 in patients with atrial fibrillation and metabolic syndrome

Event: ESC Congress 2018

Topic: Atrial Stressors

Session: Atrial fibrillation - epidemiology

Thumbnail

C(-915)G polymorphism gene of transforming growth factor 1 in patients with metabolic syndrome and atrial fibrillation

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Atrial fibrillation obesity

Thumbnail

Epicardial fat and effectiveness of catheter radiofrequency ablation in patients with atrial fibrillation and metabolic syndrome

Event: EuroEcho-Imaging 2016

Topic: The echocardiographic examination and quality assessment

Session: The imaging examination and quality assessment

Thumbnail

Can we predict the effect of antiarrhythmic pharmacotherapy in atrial fibrillation and metabolic syndrome patients: focus on galectin-3

Event: ESC Congress 2016

Topic: Atrial fibrillation (AF)

Session: Mechanism of arrhythmia in atrial fibrillation . New data on remodelling biomarkers and anti-arrhythmic drugs

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb